LexaGene Holdings Inc. (CVE:LXG – Get Free Report)’s stock price dropped 19.2% on Tuesday . The company traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares traded hands during mid-day trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Stock Performance
The stock has a 50 day moving average price of C$0.11 and a two-hundred day moving average price of C$0.11. The company has a market capitalization of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26. The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
Read More
- Five stocks we like better than LexaGene
- Manufacturing Stocks Investing
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Investing in the High PE Growth Stocks
- What Does the Future Hold for Eli Lilly?
- What is diluted earnings per share (Diluted EPS)?
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
